Effect of Robotic Assisted Therapy on Hand Functions, Grip Strength and Proprioception in Children With Hemiplegia
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 9 years old?
Source: NCT07249866, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Cairo University
- Trial code
- NCT07249866
- Record updated
- 25 November 2025
- Original description
Statement of the problem:Read full original descriptionShow less
Statement of the problem:
Does robotic assisted therapy have an effect on hand functions, grip strength and proprioception in children with hemiplegic cerebral palsy?
Significance of the study:
New technologies allow and promote active involvement, leading directly to functional changes that are far beyond those obtained with conventional therapy. Many features of robotic therapy may contribute to enhanced recovery of upper limb motor function. These include task-specific practice, intensity of repetition, robotic assistance, enhanced sensory feedback, continual motivation (because every trial yields a degree of success, even if robot assistance is required).
The implementation of robotics with hemiplegic cerebral palsy focuses on functional motor performance by providing intensive repetitive training, sensorimotor integration and cognitive engagement through goal-directed tasks to address the underlying symptoms. Robotic technologies offer numerous potential advantages over conventional therapies, chief among these being the ability to provide high-intensity repetitive training. Robotic treatment is a novel approach that has demonstrated promise in enhancing motor function, enhancing the quality of life, and lessening the burden on caregivers.
Inclusion: Their ages range from 6-9 years; They have mild to moderate spasticity (grade 1- 2) according to Modified Ashworth Scale; Their motor function will be at level I and II according to Gross Motor Function Classification System GMFCS; Their manual abilities will be at level II and Level III according to Manual Ability classification system; They will be able to understand and follow instructions.
Exclusion: Previous history of surgical intervention in the upper limb; Fixed deformity in any joints of the upper limb; Auditory, visual and cognitive problems; Botulinum Toxin injection in last 6 months.